Parenteral Nutrition Market Size, Share, Growth by 2030

The parenteral nutrition market was valued at approximately US$ 6.84 billion in 2022 and is projected to grow to US$ 11.21 billion by 2030, reflecting a compound annual growth rate (CAGR) of 6.2% during the period from 2022 to 2030.

Parenteral nutrition refers to a method of delivering essential nutrients directly into the bloodstream through intravenous means. This method encompasses a range of components, including fluids, vitamins, minerals, trace elements, amino acids, and electrolytes. Unlike enteral nutrition, which involves feeding through the gastrointestinal tract, parenteral nutrition is more intricate, often more expensive, and carries a heightened risk of infections and extended hospital stays. It is typically prescribed for patients who cannot obtain adequate nutrition through oral or enteral routes. The primary objectives of parenteral nutrition therapy are to restore nutritional balance, address hypoproteinemia, alleviate muscle weakness, and compensate for other nutritional deficiencies.

Current trends in the parenteral nutrition market highlight advancements in the formulation of nutritional products. There is an increasing demand for solutions that empower consumers to take charge of their health, particularly those tailored to specific requirements such as energy enhancement, immune support, and disease management. Nutritional needs can vary significantly depending on the underlying health conditions. The specialized formulations of parenteral nutrition products are designed to complement existing treatments, thereby providing a more targeted and effective therapeutic approach. The composition of macronutrients and micronutrients in parenteral nutrition is adapted to cater to various diseases, including cancer and gastrointestinal disorders.

Recent innovations in formulation are ushering in a new era of nutritional solutions that cater to the unique needs of individual patients and their medical conditions. This level of customization not only enhances patient outcomes but also boosts the efficacy of parenteral nutrition. Innovations in formulations allow the market to address the distinct nutritional requirements of diverse patient populations, ranging from neonates to the elderly and those with specific health issues. For instance, the introduction of lipid-based emulsions with enhanced stability and bioavailability is revolutionizing intravenous nutrition, particularly for premature infants. Furthermore, these formulation advancements mitigate the risks and side effects traditionally associated with standard nutritional solutions. The industry is poised for remarkable growth and sustained success, driven by the dual advantages of fostering the adoption of parenteral nutrition within healthcare systems and improving patient care.

Insights into the Parenteral Nutrition Market by Nutrient Type

The parenteral nutrition market is categorized by nutrient type into several segments: single dose amino acid solutions, parenteral lipid emulsions, carbohydrates, trace elements, and vitamins and minerals. In 2022, the segment for single dose amino acid solutions held the largest market share, while the parenteral lipid emulsion segment is expected to experience the highest CAGR during the forecast period. There is an increasing demand for nutritional therapies, particularly parenteral amino acids, which provide a significant protein supply without excessive energy, thereby helping to reduce protein breakdown in critically ill patients.

Insights into the Parenteral Nutrition Market by End User

Regarding end users, the parenteral nutrition market is divided into hospitals, clinics, and other facilities. The hospital segment accounted for the largest market share in 2022; however, the clinic segment is projected to achieve the highest CAGR from 2022 to 2030. Hospitals are equipped with comprehensive facilities and offer a wide range of diagnostic and treatment options that can be covered by insurance. They are staffed by various healthcare professionals, including specialists, who provide advanced medical services. Hospitals play a crucial role in treating all types of cardiovascular diseases and offer extensive medical services, including nursing care, to patients with diverse health issues. This has led to an increased adoption of transdermal drug delivery systems for various conditions and surgical procedures among hospitalized patients.

Key secondary sources utilized in the preparation of the report on the parenteral nutrition market include the Medicines and Healthcare Regulatory Authority, Element-Nutrition-Deck, Office for National Statistics, and the National Institute for Clinical Excellence.